Resource Center
Resource Center
A new study published in the Journal of the International AIDS Society highlights a CHAI-led project in seven sub-Saharan African countries to evaluate near-point-of-care (near-POC) tests used to monitor HIV viral load.
Read moreThe Market Report provides the community with the most comprehensive and reliable view into the public and social sectors of the family planning procurement market across 69 FP2020 focus countries.
Read moreA long-awaited HIV treatment designed specifically for children will now be available in low-and middle-income countries, thanks to a landmark agreement from Unitaid and the Clinton Health Access Initiative (CHAI).
Read moreFive things to know about DTG as the long-awaited HIV treatment designed specifically for children will now be available in low-and middle-income countries.
Read moreWe are pleased to release our annual report. This year's theme is 'transformational change'.
Read moreThe theme for the 2018 Annual Report is ‘Our Approach in Action’. There are examples in each program section of a time that CHAI’s approach was successfully applied to support our partners toward our mission.
Read moreIntroducing the third edition of CHAI’s HIV Mid-Year Market Memo, a brief that that covers the latest trends in the HIV space in low- and middle-income countries since the publication of CHAI’s annual HIV Market Report in September 2018. Read the HIV Mid-Year Market Memo here. Read the 2018 HIV Market Report.
Read moreThe 2017 Annual Report looks back at what we have accomplished over the year, as well as toward the goals that we have set for each of our programs over the next five to 10 years.
Read moreAmsterdam – A breakthrough pricing agreement will significantly reduce the cost of diagnostic testing for HIV/AIDS, hepatitis and cervical cancer for millions of people in low- and middle-income countries. Diagnostic testing improves patient care, helps prevent the spread of disease, and reduces healthcare spending. The new agreement, announced today at the 2018 International AIDS Conference,...
Read moreNegotiated pricing agreements have lowered costs and will improve access to quality treatment for people living with HIV New York – A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and middle-income countries...
Read more